ArticleCase reports in oncology

Rituximab Twice Weekly for Refractory Thrombotic Thrombocytopenic Purpura in a Critically Ill Patient with Acute Respiratory Distress Syndrome.

Bahjat Azrieh et al.PubMed ↗Full text ↗Publisher ↗

No numbers read from the abstract.